New and updated products from the Congressional Research Service that Congress has not made readily available to the public include the following.
Cloud Computing: Constitutional and Statutory Privacy Protections, March 22, 2013
The National Broadband Plan Goals: Where Do We Stand?, March 19, 2013
U.S. Customs and Border Protection: Trade Facilitation, Enforcement, and Security, March 22, 2013
Itemized Tax Deductions for Individuals: Data Analysis, March 21, 2013
International Monetary Fund: Background and Issues for Congress, March 21, 2013
China Naval Modernization: Implications for U.S. Navy Capabilities — Background and Issues for Congress, March 21, 2013
Former Presidents: Pensions, Office Allowances, and Other Federal Benefits, March 21, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.